|
Recent Developments |
|
06-MAY-11
The board of directors of Jyothy Laboratories (JLL) has approved the buy-out of 50.97% stake in Henkel India (HIL) from Henkel AG & Co. KGaA (Henkel AG).
... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (15) | 31-Dec-2010 (12) | | Net sales | 2450.70 | 4480.10 | 4501.70 | | Other Income | 1.80 | 43.80 | 53.90 | | Total Income | 2452.50 | 4523.90 | 4555.60 | | Cost of goods sold | 2386.80 | 4231.30 | 4312.80 | | OPBDIT | 65.70 | 292.60 | 242.80 | | PAT | -122.00 | -605.70 | 11.30 | | Gross Block | - | - | - | | Equity capital | 1164.60 | 1164.60 | 1164.60 | | EPS (Rs.) | - | -5.20 | 0.10 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | 297.50 - 760.00 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 2.7 | 6.5 | 5.3 | | Net margin (% of OI) | -5.0 | -13.4 | 0.2 |
|
|
Detailed Financials
|
|
|
|
|
